Lewis-Hall Freda C
Insider transactions at 6 companies
This page shows all SEC Form 4 filings attributed to Lewis-Hall Freda C. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CDTTW | Award / Grant | 35,000 | — | — | Aug 12, 2025 | |
| 0001773427 | Disposition | 24,727 | — | — | Jul 1, 2025 | |
| 0001773427 | Award / Grant | 10,060 | — | — | May 14, 2025 | |
| CDTTW | Award / Grant | 47,612 | $0.89 | $42,375 | Mar 30, 2025 | |
| CDTTW | Award / Grant | 437,976 | $0.09 | $39,418 | Nov 18, 2024 | |
| 0001773427 | Award / Grant | 4,095 | — | — | May 16, 2024 | |
| PYXS | Award / Grant | 35,219 | — | — | Mar 26, 2024 | |
| EXAS | Award / Grant | 3,599 | — | — | Jun 8, 2023 | |
| 0001773427 | Award / Grant | 4,648 | — | — | May 24, 2023 | |
| PYXS | Award / Grant | 139,355 | — | — | Mar 24, 2023 | |
| 0001404123 | Disposition | 4,534 | $18.00 | $81,612 | Feb 22, 2023 | |
| EXAS | Award / Grant | 5,606 | — | — | Jun 9, 2022 | |
| 0001404123 | Option Exercise | 4,534 | — | — | Jun 2, 2022 | |
| 0001773427 | Award / Grant | 4,818 | — | — | May 19, 2022 | |
| PYXS | Award / Grant | 66,831 | — | — | Mar 31, 2022 | |
| EXAS | Award / Grant | 2,011 | — | — | Jun 30, 2021 | |
| 0001773427 | Award / Grant | 1,106 | — | — | May 20, 2021 | |
| EXAS | Award / Grant | 3,408 | — | — | Jul 23, 2020 | |
| EXAS | Award / Grant | 5,064 | — | — | Apr 22, 2020 | |
| 0001773427 | C | 978,194 | — | — | Sep 17, 2019 | |
| PFE | Executive Vice President | Tax Withholding | 50,317 | $42.31 | $2,128,912 | Feb 27, 2019 |
| PFE | Executive Vice President | Tax Withholding | 27,230 | $41.91 | $1,141,209 | Feb 23, 2019 |
| PFE | Executive Vice President | Tax Withholding | 20,136 | $36.31 | $731,138 | Feb 28, 2018 |
| PFE | Executive Vice President | Tax Withholding | 21,078 | $37.09 | $781,783 | Feb 26, 2018 |
| PFE | Executive Vice President | Tax Withholding | 26,555 | $36.26 | $962,884 | Feb 24, 2018 |
| PFE | Executive Vice President | Tax Withholding | 8,515 | $34.28 | $291,894 | Feb 27, 2017 |
| PFE | Executive Vice President | Option Exercise | 103,155 | $21.03 | $2,169,350 | Feb 23, 2017 |
| THC | Award / Grant | 7,984 | — | — | May 13, 2016 | |
| PFE | Executive Vice President | Award / Grant | 9,780 | — | — | Feb 28, 2016 |
| PFE | Executive Vice President | Tax Withholding | 52,367 | $29.67 | $1,553,729 | Feb 24, 2016 |
| THC | Award / Grant | 4,722 | — | — | May 8, 2015 | |
| PFE | Executive Vice President | Option Exercise | 101,351 | $17.69 | $1,792,899 | Feb 25, 2015 |
| PFE | Executive Vice President | Tax Withholding | 8,196 | $34.39 | $281,860 | Feb 23, 2015 |
| THC | Award / Grant | 2,608 | $52.44 | $136,764 | Dec 24, 2014 | |
| PFE | Executive Vice President | Award / Grant | 34,085 | — | — | Feb 26, 2014 |
| PFE | Executive Vice President | Tax Withholding | 18,175 | $31.99 | $581,418 | Feb 24, 2014 |
| PFE | Executive Vice President | Sale | 38,461 | $28.70 | $1,103,831 | Sep 16, 2013 |
| PFE | Executive Vice President | Award / Grant | 43,717 | — | — | Feb 28, 2013 |
| PFE | Executive Vice President | Tax Withholding | 11,637 | $26.84 | $312,337 | Feb 25, 2013 |
| PFE | Executive Vice President | Tax Withholding | 35,979 | $22.18 | $798,014 | May 29, 2012 |
| PFE | Executive Vice President | Award / Grant | 20,028 | — | — | Feb 23, 2012 |
| PFE | Executive Vice President | Award / Grant | 39,439 | — | — | Feb 24, 2011 |
| PFE | Senior Vice President | Award / Grant | 25,070 | — | — | Feb 25, 2010 |
| PFE | Senior Vice President | Award / Grant | 65,833 | — | — | May 29, 2009 |
| VRTX | EVP, Medicines Development | Sale | 1,250 | $29.11 | $36,388 | Mar 19, 2009 |
| VRTX | EVP, Medicines Development | Award / Grant | 12,084 | $0.01 | $121 | Feb 5, 2009 |
| VRTX | EVP, Medicines Development | Sale | 1,250 | $29.90 | $37,375 | Dec 19, 2008 |
| VRTX | EVP, Medicines Development | Sale | 152 | $26.00 | $3,952 | Dec 11, 2008 |
| VRTX | EVP, Medicines Development | Award / Grant | 35,000 | $0.01 | $350 | Jun 18, 2008 |